Popular topics to explore
ZEEL
has been a focal point of news today, June 23, 2025, primarily due to a significant promoter capital infusion and a renewed strategic business outlook. This has led to a sharp increase in its stock price.
The company's shares surged over 9-11% today after the announcement that its promoters plan to infuse ₹2,237 crore into the company. This will be done through the issuance of fully convertible warrants at a price of ₹132 per warrant, which is above the SEBI-prescribed floor price. This capital infusion, subject to shareholder approval at an Extraordinary General Meeting (EGM) on July 10, 2025, is aimed at strengthening ZEEL's balance sheet and enabling future growth. Post-conversion, the promoter stake is expected to rise to 18.39%.
This strategic move is accompanied by a clear roadmap for the company's next phase of growth. ZEEL aims to achieve breakeven for its digital platform, ZEE5, which incurred an EBITDA loss of ₹548 crore in FY25. The company also plans to expand into new content formats like micro-dramas, edutainment, and emerging sports, while actively exploring inorganic growth through mergers and acquisitions in content and technology.
Financially, ZEEL reported a net profit of ₹188.4 crore in Q4 FY25, a significant increase from ₹13.4 crore in Q4 FY24. Its cash and cash equivalents also saw a 102% increase to ₹2,406 crore as of March 2025. The company is targeting an 18-20% EBITDA margin for FY26, a notable improvement from 14.4% in FY25, driven by cost control measures and a reduction in Zee5 losses.#StockInNews#WatchOutFor#FundamentalViews#EquityResearch#PersonalFinance
2 likes

















